Category: HPB & Spleen

Tumour Biology Characteristics Score Predicts Outcome in HCC Patients

A novel tumour biology characteristics score (TBCS), utilizing alpha-fetoprotein and PIVKA-II levels, significantly predicts recurrence-free survival (RFS) and overall survival (OS) in hepatocellular carcinoma (HCC) patients post-resection. Analysis of 695 patients revealed distinct survival outcomes across TBCS groups: 5-year RFS and OS were lowest in the high TBCS group (9.7% and 23.5%, respectively). TBCS serves […]

Postoperative hepatic insufficiency still occurs in 12% of patients.

Despite achieving the desired future liver remnant volume through portal vein embolization, 12% of patients still experienced postoperative hepatic insufficiency following major hepatectomy. Key risk factors identified include older age, performance status, preoperative biliary drainage, and specific diagnoses such as cholangiocarcinoma or gallbladder cancer. Notably, postoperative hepatic insufficiency significantly increased mortality rates from 3.5% to […]

Tumor burden score improves survival prediction in liver cancer.

A new classification for hepatocellular carcinoma enhances predictive accuracy for overall survival. In a study involving 1,766 patients, incorporating the tumor burden score (TBS) allowed reclassification into distinct categories, revealing improved five-year survival rates: the TBS-br model yielded rates of 70.8%, 58.3%, and 40.0% compared to the original boundary category’s 65.1%, 48.2%, and 46.4%. This […]

SmartPAN demonstrates safe and effective intraoperative pancreatic leakage visualization

In a first-in-human trial, SmartPAN hydrogel proved safe and easy to use for visualizing intraoperative pancreatic leakage during partial resections. Out of 29 patients receiving SmartPAN, 10 demonstrated positive leakage responses, with postoperative pancreatic fistula (POPF) occurring in 7 patients. Surgeons rated the device highly for its usability and expressed intent to use it frequently. […]

Machine learning effectively predicts optimal outcomes in liver surgery

A machine learning model successfully predicted textbook outcomes in liver surgery using preoperative data from over 2,000 patients. The top-performing xgboost model achieved an area under the curve of 0.73. Significant predictors included minimally invasive techniques and patient characteristics such as lower comorbidity scores. Furthermore, meeting textbook outcome criteria was associated with improved overall survival, […]

Conditional survival predictions enhance outcomes for pancreatic cancer patients

A study on pancreatic ductal adenocarcinoma reveals that conditional survival analysis based on kallikrein-related peptidase 7 (klk7) expression can significantly improve prognostic assessments. Results show that 1-, 2-, and 3-year conditional survival rates increased from 50.4% to 91.2%, while overall survival rates dropped from 81.9% to 38.6%. Patients surviving longer periods demonstrate improved future survival […]

Serum Transaminase Changes Predict Postoperative Complications in Liver Resection

Dynamic changes in serum AST and ALT levels after liver resection for hepatocellular carcinoma were shown to significantly impact postoperative morbidity. In a study involving 759 patients, an increase in the combined assessment of AST and ALT (caa) to ≥5 was strongly linked to higher complication rates, with an odds ratio of 1.63. The study […]

Achievement of textbook outcomes improves survival in HPB surgery

A systematic review and meta-analysis evaluated textbook outcomes (TOs) in hepatopancreaticobiliary (HPB) surgery across 27 studies involving 517,304 patients. It revealed a median TO achievement rate of 62% for hepatic procedures, 54% for biliary, and lower rates for pancreatic and liver transplantation surgeries. Importantly, achieving TOs was linked to an increased likelihood of 5-year overall […]

Blood tests enhance differentiation between liver cancer types

A study involving 165 patients diagnosed with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) identified alpha-fetoprotein (AFP) and carbohydrate antigen 19-9 (CA19-9) as key tumor markers for accurate preoperative differentiation. Elevated white blood cell counts, neutrophil-to-lymphocyte ratios, and monocyte counts were linked to increased ICC risk, while higher lymphocyte-to-monocyte ratios indicated protection. The predictive model […]